I don't believe anybody who has been associated with Intellect, past or present, will have any affect on a buyout here. Pharmas are looking at the science, and if the science has the ability to eventually make them money. I believe Intellect holds the science that can make Pharmas a lot of money. Even though Dr. Chain, a man who abandoned Intellect and its shareholders and who has absolutely no integrity, has started a new company, I still believe Intellect holds possible treatments for many different neurological diseases and that is the bottom line. Intellect being associated with Blech/Chassman or whoever else doesn't matter when it comes down to the science. All in my opinion. Hope everyone here gets the buyout price they are looking for eventually. GLTA
